Detalles de la búsqueda
1.
Plasma level-dependent effects of methylphenidate on task-related functional magnetic resonance imaging signal changes.
Psychopharmacology (Berl)
; 180(4): 624-33, 2005 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-15830222
2.
Adrenaline in the CNS: in vivo evidence for a functional pathway innervating the hypothalamus.
Neuropharmacology
; 26(7B): 823-30, 1987 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-2889157
3.
Enhancement of 5-HT1B and 5-HT1D receptor antagonist effects on extracellular 5-HT levels in the guinea-pig brain following concurrent 5-HT1A or 5-HT re-uptake site blockade.
Neuropharmacology
; 38(9): 1409-19, 1999 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-10471095
4.
In vivo characterization of the putative 5-HT1A receptor antagonist SDZ 216,525 using two models of somatodendritic 5-HT1A receptor function.
Neuropharmacology
; 33(3-4): 359-66, 1994.
Artículo
en Inglés
| MEDLINE | ID: mdl-7984274
5.
Importance of h5-HT1B receptor selectivity for 5-HT terminal autoreceptor activity: an in vivo microdialysis study in the freely-moving guinea-pig.
Neuropharmacology
; 36(4-5): 549-57, 1997.
Artículo
en Inglés
| MEDLINE | ID: mdl-9225280
6.
Evidence to suggest that agonist modulation of hyperlocomotion is via post-synaptic dopamine D2 or D3 receptors.
Neuropharmacology
; 36(6): 787-92, 1997 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-9225306
7.
Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D(3) receptor antagonist with high oral bioavailability and CNS penetration in the rat.
J Med Chem
; 43(9): 1878-85, 2000 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-10794704
8.
The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo.
J Med Chem
; 41(8): 1218-35, 1998 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-9548813
9.
Electrical stimulation of the C1 region of the rostral ventrolateral medulla of the rat increases mean arterial pressure and adrenaline release in the posterior hypothalamus.
Neuroscience
; 20(2): 457-66, 1987 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-2438591
10.
Differential effects of potassium channel blockers on extracellular concentrations of dopamine and 5-HT in the striatum of conscious rats.
Br J Pharmacol
; 116(8): 3260-4, 1995 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-8719805
11.
The 5-HT1 receptor agonist RU-24969 decreases 5-hydroxytryptamine (5-HT) release and metabolism in the rat frontal cortex in vitro and in vivo.
Br J Pharmacol
; 86(1): 209-16, 1985 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-2413936
12.
Involvement of central alpha- and beta-adrenoceptors in the pressor response to electrical stimulation of the rostral ventrolateral medulla in rats.
Br J Pharmacol
; 94(2): 609-19, 1988 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-2840166
13.
Characterization of [(125)I]-SB-258585 binding to human recombinant and native 5-HT(6) receptors in rat, pig and human brain tissue.
Br J Pharmacol
; 130(7): 1597-605, 2000 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-10928963
14.
Characterization of SB-271046: a potent, selective and orally active 5-HT(6) receptor antagonist.
Br J Pharmacol
; 130(7): 1606-12, 2000 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-10928964
15.
Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivity.
Psychopharmacology (Berl)
; 153(2): 210-8, 2001 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11205421
16.
Development of 5-HT1A receptor antagonists.
Behav Brain Res
; 73(1-2): 153-6, 1996.
Artículo
en Inglés
| MEDLINE | ID: mdl-8788494
17.
Comparison of the effects of selected drugs on the release of hypothalamic adrenaline and noradrenaline measured in vivo.
Brain Res
; 426(1): 103-11, 1987 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-2446707
18.
Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in vivo microdialysis study.
Eur J Pharmacol
; 239(1-3): 195-202, 1993 Aug 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-8223894
19.
Differential effects of WAY-100135 on the decrease in 5-hydroxytryptamine release induced by buspirone and NAN-190.
Eur J Pharmacol
; 276(3): 281-4, 1995 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-7601215
20.
Differential effects of 5-HT1B/1D receptor antagonists in dorsal and median raphe innervated brain regions.
Eur J Pharmacol
; 346(2-3): 175-80, 1998 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-9652357